Assenagon Asset Management’s Core Laboratories CLB Stock Holding History

Assenagon Asset Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-12,842	Closed	-$287K	–	1431
2021 Q4	$287K	Sell	12,842 -35,567	-73%	-$928K	﹤0.01%	1305
2021 Q3	$1.34M	Buy	+48,409	New	+$1.47M	﹤0.01%	824
2021 Q2	–	Sell	-8,604	Closed	-$248K	–	1232
2021 Q1	$248K	Buy	+8,604	New	+$294K	﹤0.01%	1134
2017 Q3	–	Sell	-17,769	Closed	-$1.8M	–	461
2017 Q2	$1.8M	Buy	17,769 +14,199	+398%	+$1.53M	0.04%	123
2017 Q1	$412K	Buy	+3,570	New	+$415K	0.01%	227

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

CPH

C Partners Holding Zurich, Switzerland $330M AUM 11.92% 1-Year Est. Return

Assenagon Asset Management's CLB Position: Q1 2022 in Review

Assenagon Asset Management sold out of Core Laboratories (CLB) in Q1 2022, closing a stake of 12,842 shares — an estimated $287K sold.

Assenagon Asset Management first reported a position in CLB in Q1 2017 and held it in 5 quarters. The position peaked at $1.8M in Q2 2017. 196 funds tracked by Wall St. Rank hold CLB as of Q1 2022.

Assenagon Asset Management reported no remaining Core Laboratories position as of Q1 2022 after selling out during the quarter.
Assenagon Asset Management sold 12,842 Core Laboratories shares in Q1 2022, an estimated $287K.
Assenagon Asset Management first reported a position in Core Laboratories in Q1 2017 and held it in 5 quarters.
Assenagon Asset Management's Core Laboratories position peaked at $1.8M in Q2 2017.
196 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2022.

Based on Assenagon Asset Management's 13F filing for Q1 2022, filed 25 Apr 2022.